What Is Cancer Rehabilitation and How Can it Help My Patients? |
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Parenting with Cancer |
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Cancer Related Pain Management from a Palliative Care Perspective |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS Category A
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
The Umbrella and the Kitchen Table: Providing Safe, Supportive Care for Cancer Patients |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Dos, Don’ts, and the Basics of Providing Care to Patients Experiencing Intimate Partner Violence |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
The Value of Integrative Medicine in Oncology Care |
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Radiation Oncology Management of Lung Cancer in NC: Update on Small-Cell Lung Cancer |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Occupational Therapy and Cancer Rehabilitation |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Demystifying Molecular-Based Tests in Head and Neck Cancers |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Cancer Pathology: How Diagnosis Drives Treatment |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Cardiovascular Toxicities of Cancer Therapies |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
GVHD: An Overview of Graft vs Host Disease Post Hematopoietic Stem Cell Transplant |
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Oncologic Emergencies: Superior Vena Cava Syndrome, Hypercalcemia, and SIADH |
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Lung Cancer Screening Essentials |
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |